Our Services
Medical Information
Helpful Resources
Published on: 5/5/2026
Doctors can preserve and enhance your NMN gains by blocking the CD38 enzyme with investigational drugs, natural modulators like quercetin and apigenin, and lifestyle interventions such as an anti-inflammatory diet, exercise, and sleep optimization. This approach helps maintain higher NAD+ levels for improved energy, cellular repair, and healthy aging.
There are several factors to consider, and you can review complete details below to guide your next steps in dosing, monitoring, and safety.
Nicotinamide mononucleotide (NMN) has emerged as a leading supplement for supporting cellular energy, metabolic health, and healthy aging. But one key challenge stands in the way of maximizing NMN's benefits: the CD38 enzyme. In this guide, we explain in clear, common language how your doctor can help you block the CD38 enzyme to preserve and enhance your NMN gains.
NMN is a precursor to nicotinamide adenine dinucleotide (NAD+), a critical coenzyme involved in:
As we age, NAD+ levels decline, which can contribute to fatigue, metabolic slowdown, and diminished cellular repair.
The CD38 enzyme is a membrane-bound protein found on many cell types, including immune cells. Its main function is to break down NAD+ and related molecules. While CD38 plays important roles in calcium signaling and immune response, excessive CD38 activity can deplete NAD+ stores, undermining the benefits of NMN supplementation.
By inhibiting the CD38 enzyme, you can:
Blocking CD38 isn't about shutting down a vital protein entirely; it's about modulating its activity so that the NAD+ you generate from NMN isn't rapidly dismantled.
Your doctor may recommend a multi-pronged approach combining prescription options, nutraceuticals, and lifestyle tactics:
While still under clinical investigation, certain CD38 inhibitors have shown promise:
Your doctor will weigh potential benefits against risks, side effects, and regulatory status before considering any prescription approach.
Several plant-derived compounds have been shown in lab studies to dampen CD38 enzyme activity:
Typical supplemental dosages used in research:
These compounds may not fully block CD38 but can help tip the balance in favor of higher NAD+ levels.
Lifestyle changes that reduce CD38 expression and support NAD+ include:
• Anti-inflammatory diet
– Emphasize colorful vegetables, fatty fish, nuts, and seeds
– Minimize processed foods, refined sugars, and excessive alcohol
• Regular exercise
– Both aerobic (walking, cycling) and resistance training
– Exercise can downregulate CD38 expression in tissues
• Stress management
– Chronic stress elevates inflammatory signals that boost CD38
– Practices such as meditation, yoga, or deep breathing help maintain healthy CD38 levels
• Sleep optimization
– Aim for 7–8 hours of quality sleep each night
– Poor sleep increases oxidative stress and may drive CD38 up
Because each individual's biology is unique, your doctor will personalize your protocol:
Baseline assessments
Follow-up testing
Safety monitoring
If you experience symptoms that worry you—such as unexplained fatigue, chest discomfort, or severe digestive issues—consult a healthcare professional right away. You can also get personalized guidance by using a Medically approved LLM Symptom Checker Chat Bot to help identify potential concerns before your appointment.
Always discuss your plans, supplements, and any new therapies with a qualified healthcare professional. If you suspect anything life threatening or serious, please speak to a doctor immediately.
(References)
* Chini EN, Chini CC, Hogan KA. NAD+ metabolism and its therapeutic potential for CD38-related diseases. J Cell Mol Med. 2023 Aug;27(16):2410-2419. doi: 10.1111/jcmm.17387. Epub 2023 Jul 14. PMID: 37452377; PMCID: PMC10437454.
* Mishra P, Mishra A. CD38 at the crossroads of NAD+ metabolism in cancer: from a metabolic enzyme to a therapeutic target. Mol Cell Biochem. 2023 Jun;478(6):1443-1454. doi: 10.1007/s10495-022-01740-4. Epub 2022 Aug 4. PMID: 35922757; PMCID: PMC9350410.
* Chini EN, Chini CC, Hogan KA, Kanamori Y, Ab मान्न M. CD38 as a Therapeutic Target in Inflammatory Diseases: Modulating NAD+ Metabolism and Immune Responses. Int J Mol Sci. 2023 Apr 29;24(9):8048. doi: 10.3390/ijms24098048. PMID: 37298018; PMCID: PMC10179124.
* Hogan KA, Chini EN. CD38, a new target for drug discovery. Drug Discov Today. 2017 May;22(5):792-798. doi: 10.1016/j.drudis.2017.02.007. Epub 2017 Feb 22. PMID: 28238806; PMCID: PMC5407066.
* Zhang J, Xiang H, Liu J, Yin J, Peng K, Yu Y, Deng S, Liu B, Liu W. The NAD+-biosynthetic enzyme NMNAT2 counteracts CD38-mediated NAD+ depletion and provides neuroprotection. Proc Natl Acad Sci U S A. 2018 Jan 23;115(4):E716-E724. doi: 10.1073/pnas.1714407115. Epub 2018 Jan 9. PMID: 29339485; PMCID: PMC5798363.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.